跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lofepramine
首页
药物
Lofepramine
Experimental
Small Molecule
Lofepramine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
26
H
27
ClN
2
O
CAS 编号
23047-25-8
UNII ID
OCA4JT7PAW
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Treatment of fatigue, head injury and stroke
申请人: LAXDALE LTD
优先权: 1999
US
Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tyrptophan and possibly a vitamin B12 compound
申请人: LODER CARI
优先权: 2000
US
Use of Pharmaceutical Compositions of Lofepramine for the Treatment of Adhd, Cfs, Fm and Depression
申请人: DINAN TIMOTHY
优先权: 2005
US
TREATMENT AND PREVENTION OF DEPRESSION WITH PAIN, DEPRESSION SECONDARY TO PAIN, AND OF NEUROPATHIC PAIN
申请人: DINAN TIMOTHY
优先权: 2007
US
Dispersible tablet containing antipsychotic medicines and application thereof
申请人: DINGHAO WANG
优先权: 2011
CN
药物
反馈